Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

Researchers associated with the New York-based Memorial Sloan Kettering Cancer Center have obtained positive results in the ...

For decades, researchers have worked to create drugs that teach the immune system to kill cancer cells the way traditional ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

Cash and cash equivalents at the end of fourth quarter of 2024 of approximately $60.0 million; secured up to €57.5 million in debt financing from the European Investment Bank (EIB); the company ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

"If you can do this in pancreas cancer, theoretically you may be able to develop therapeutic vaccines for other cancer types." ...

A federal vaccine advisory panel work session focused on next year's flu shot has been canceled without explanation.

This is where cancer vaccines could provide an alternative, effective therapy. Larger companies that are working in the space, such as Moderna, share the same belief, but with another approach.